A good resource play. Good conglomorate giving morfe downturn protection, but can limit your upside. Would prefer an Alcan or Inco. Would buy in the mid $20's.
Has been treating as a trading stock. Sometimes the stock drops for no reason, so it creates a buying opportunity. Has been growing its earnings at 100% year over year.